Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701478-25-000018
Filing Date
2025-05-13
Accepted
2025-05-13 17:00:48
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aztr-20250331.htm   iXBRL 10-Q 876088
2 EX-31.1 aztr-20250331xexx311.htm EX-31.1 10025
3 EX-31.2 aztr-20250331xexx312.htm EX-31.2 10454
4 EX-32.1 aztr-20250331xexx321.htm EX-32.1 8461
10 aztr-20250331_g1.jpg GRAPHIC 6997
11 aztr-20250331_g2.jpg GRAPHIC 90435
  Complete submission text file 0001701478-25-000018.txt   6336293

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aztr-20250331.xsd EX-101.SCH 50976
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aztr-20250331_cal.xml EX-101.CAL 58730
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aztr-20250331_def.xml EX-101.DEF 227998
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aztr-20250331_lab.xml EX-101.LAB 645420
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aztr-20250331_pre.xml EX-101.PRE 449024
81 EXTRACTED XBRL INSTANCE DOCUMENT aztr-20250331_htm.xml XML 700562
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41705 | Film No.: 25941129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)